[Skip to Content]
[Skip to Content Landing]
March 1998

Intra-arterial ChemotherapyA Welcome New Idea for the Management of Adenocystic Carcinoma of the Lacrimal Gland

Arch Ophthalmol. 1998;116(3):372-373. doi:10.1001/archopht.116.3.372

ADENOCYSTIC CARCINOMA is an aggressive disease with a propensity for perineural, hematogenous, and lymphatic invasion. The prognosis is grim: approximately 70% to 80% of patients succumb to the disease within 10 years of diagnosis despite aggressive and often disfiguring treatment, and recurrences can occur 15 or 20 years after excision, making true cures extremely rare.1,2

First Page Preview View Large
First page PDF preview
First page PDF preview